Archive for September, 2005

Fondaparinux: Better than Enoxaparin for Patients with Acute Coronary Syndromes?

Freek Verheugt
Freek Verheugt

Shamir Mehta of McMaster University told Audio Medica in Stockholm about the OASIS-5/MICHELANGELO results comparing the new anti-thrombotic therapy, fondaparinux, with enoxaparin among patients with acute coronary syndromes. For a comment on Shamir Mehta’s presentation at the ESC meeting, Audio Medica questioned Freek Verheugt of Nijmegen.
Shamir Mehta:
Freek Verheugt:

Click here for all the interviews from ESC 2005

Subscribe to Audio Medica Podcast